Periconceptional vitamin a use: How much is teratogenic?
Open Access
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Reproductive Toxicology
- Vol. 12 (1) , 75-88
- https://doi.org/10.1016/s0890-6238(97)00102-0
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- All-Trans-Retinoic Acid in Maternal Plasma and Teratogenicity in Rats and RabbitsToxicology and Applied Pharmacology, 1996
- High maternal vitamin A intake and risk of anomalies of structures with a cranial neural crest cell contributionThe Lancet, 1996
- Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13‐cis‐retinoic acid (isotretinoin) in the cynomolgus monkeyTeratology, 1994
- Tissue levels of retinoids in human embryos/fetusesReproductive Toxicology, 1993
- Maternal vitamin A supplementation in relation to selected birth defectsTeratology, 1990
- Induction of malformations in the cynomolgus monkey with 13‐cis retinoic acidTeratology, 1990
- The Absence of a Relation between the Periconceptional Use of Vitamins and Neural-Tube DefectsNew England Journal of Medicine, 1989
- Embryonic Retinoid Concentrations after Maternal Intake of IsotretinoinNew England Journal of Medicine, 1989
- Retinoic Acid EmbryopathyNew England Journal of Medicine, 1985
- Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoidsJournal of the American Academy of Dermatology, 1982